Skip to content

A Feasibility Device Study to Prevent Female Urinary Stress Incontinence

Randomized, Crossover Feasibility Study of a Device to Prevent Female Urinary Stress Incontinence

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03010800
Enrollment
8
Registered
2017-01-05
Start date
2017-01-04
Completion date
2017-05-03
Last updated
2018-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress Incontinence, Female

Brief summary

This study will test the acute efficacy of an investigational device (Yoni.Fit) in a clinical trial of women with incontinence in a standardized set of challenges performed with and without the device in place.

Detailed description

1. Potential subjects will be pre-qualified by a 6-item questionnaire, the validated Questionnaire for Urinary Incontinence Diagnosis (QUID). This questionnaire has 3 questions each referring to the seriousness of Stress Urinary Incontinence (SUI) and of Urge Urinary Incontinence (UUI). Subjects will be accepted if their SUI score is 5 or greater and is greater than the UUI score. For privacy reasons, these scores will not be retained. Subjects will then be given an appointment. Subjects will be instructed to wear comfortable athletic type wear and not to drink any fluid for two hours prior to their appointment. 2. When subjects appear for their appointment, subjects will be administered the informed consent by the Study Coordinator. All paperwork will be pre-numbered with a code that will link to the subject name. The key will be kept confidential by the Study Coordinator. They will be instructed to empty their bladders and will be given a liter of water or other drink and instructed to drink it over a 15-20 minute time period. An abbreviated patient history will be obtained for the purpose of establishing whether the subject meets the inclusion criteria and is not disqualified by meeting the exclusion criteria. The subject will again fill out the QUID questionnaire. The inclusion criteria are a SUI score of 5 or greater, predominately SUI (SUI score\>UUI score) and age between 25 and 65. Exclusion criteria are predominantly UUI, prolapse greater than mild, hysterectomy or other pelvic floor surgery other than a Caesarian section, diabetes, pregnant, BMI\>35 or unable to perform ten jumping jack exercises. Patients will be administered three additional questionnaires in order to compute a Severity Score. These questionnaires are the Urinary Distress Inventory (UDI), Urinary Impact Questionnaire (UIQ) and the Incontinence Severity Index (ISI). The scores will be multiplied together to provide the Severity Score. 3. Patients will be randomized to Group A or Group B to participate in an abbreviated Pad Test. Group A will perform the test with the Yoni.Fit device in place then repeat the test without the device. Group B will perform the test without the Yoni.Fit device in place then repeat the test with the device in place. This test has been validated (5). An hour after finishing the liter of liquid, the subject is given a tared incontinence pad, which is then put in place. She then engages in the following mild exercise challenges.. 1. Stand from sitting 10 times. 2. Cough vigorously while standing. 3. Bend down to pick up small object. 4. Perform ten jumping jacks. The subject then will remove pad, place into bag and seal. The Experimenter will then weigh pad. The subjects will be randomized so that half will perform the Abbreviated Pad Test with the Yoni.Fit device in place followed by repeating without the device in place. The other half will perform the challenges in the reverse order. 4. The experimenter will calculate a change in score, which is the weight of the pad worn without the device in place minus the tare weight of the pad divided by the weight of the pad with the device in place minus the tare weight of the pad. In case no urine is released with the device in place, the Improvement Score will be defined as 1000. A Release Change will also be calculated as the net weight without the device in place minus the weight with the device in place divided by the net weight released without the device in place.

Interventions

DEVICEWith Yoni.Fit

Abbreviated Pad Test with Yoni.Fit first, then without Yoni.Fit.

DEVICEWithout Yoni.Fit

Abbreviated Pad Test without Yoni.Fit, then with Yoni.Fit.

Sponsors

University of Oklahoma
CollaboratorOTHER
Watkins Conti Products. Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Urinary Incontinence Diagnosis (QUID). This questionnaire has 3 questions each referring to the seriousness of Stress Urinary Incontinence (SUI) and of Urge Urinary Incontinence (UUI). Subjects will be accepted if their SUI score is 5 or greater and is greater than the UUI score.

Exclusion criteria

* Refusal to sign the informed consent document * SUI score is less than 5 or is less than the UUI score. * Predominantly UUI * Prolapse greater than mild * Hysterectomy or other pelvic floor surgery other than a Caesarian section * Diabetes, * Pregnant, * BMI\>35 or unable to perform ten jumping jack exercises.

Design outcomes

Primary

MeasureTime frameDescription
Pad Weight DifferenceAn hour after finishing a liter of liquidComparison of urine weight of the pad without Yoni,Fit to the weight of the pad with Yoni.Fit controlling for the tare weight.

Countries

United States

Participant flow

Participants by arm

ArmCount
With Yoni.Fit First
With the Yoni.Fit first, then without the Yoni.Fit.
4
Without Yoni.Fit First
Without the Yoni.Fit first, then with the Yoni.Fit.
4
Total8

Baseline characteristics

CharacteristicWith Yoni.Fit FirstWithout Yoni.Fit FirstTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
4 Participants4 Participants8 Participants
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
4 Participants4 Participants8 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 80 / 8
other
Total, other adverse events
0 / 80 / 8
serious
Total, serious adverse events
0 / 80 / 8

Outcome results

Primary

Pad Weight Difference

Comparison of urine weight of the pad without Yoni,Fit to the weight of the pad with Yoni.Fit controlling for the tare weight.

Time frame: An hour after finishing a liter of liquid

ArmMeasureGroupValue (NUMBER)
With Yoni.FitPad Weight DifferenceSubject #10.0 grams
With Yoni.FitPad Weight DifferenceSubject #50.1 grams
With Yoni.FitPad Weight DifferenceSubject #30.1 grams
With Yoni.FitPad Weight DifferenceSubject #60.1 grams
With Yoni.FitPad Weight DifferenceSubject #20.0 grams
With Yoni.FitPad Weight DifferenceSubject #70.2 grams
With Yoni.FitPad Weight DifferenceSubject #40.3 grams
With Yoni.FitPad Weight DifferenceSubject #817.3 grams
Without Yoni.FitPad Weight DifferenceSubject #89.2 grams
Without Yoni.FitPad Weight DifferenceSubject #10.0 grams
Without Yoni.FitPad Weight DifferenceSubject #20.3 grams
Without Yoni.FitPad Weight DifferenceSubject #32.4 grams
Without Yoni.FitPad Weight DifferenceSubject #40.4 grams
Without Yoni.FitPad Weight DifferenceSubject #510.5 grams
Without Yoni.FitPad Weight DifferenceSubject #66.0 grams
Without Yoni.FitPad Weight DifferenceSubject #70.0 grams
Comparison: Null hypothesis is that the pad weights With Yoni.Fit and Without Yoni.Fit are equivalent.~A one-sided Wilcoxson paired T-test of the group means will be performed. If the p-value is significant, the null hypothesis will be rejected.p-value: 0.0469Wilcoxon (Mann-Whitney)

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026